Optic nerve involvement in


Journal

Ophthalmic genetics
ISSN: 1744-5094
Titre abrégé: Ophthalmic Genet
Pays: England
ID NLM: 9436057

Informations de publication

Date de publication:
04 2023
Historique:
pubmed: 6 12 2022
medline: 25 3 2023
entrez: 5 12 2022
Statut: ppublish

Résumé

Congenital Stationary Night Blindness (CSNB) constitutes a group of non-progressive retinal disorders characterized by disturbances in scotopic vision and/or by a delay in adaptation to darkness, as well as by low visual acuity, myopia, nystagmus, and strabismus. Color vision and fundus appearance tend to be normal. To date, several CACNA1F gene variants have been linked to a CSNB phenotype but only few reports have focused on the optic nerve in this disease. Twelve patients underwent standard ophthalmological and genetic evaluation including spectral domain optical coherence tomography (SD-OCT), full-field electroretinography (ffERG), kinetic perimetry, fundus photography, magnetic resonance imaging (MRI), and next-generation sequencing (NGS). Bilateral thinning of the peripapillary nerve fiber layer (pRNFL) and the ganglion cell complex (GCC) supported involvement of the optic nerves. MRI, when available, was assessed for gross intracranial optic pathway abnormalities. All patients were shown to carry pathogenic variants in the CACNA1F gene, and all showed signs of optic nerve involvement. All patients showed a certain degree of myopic refractive error. Low average pRNFL thickness was evident in all patients. In three of them, pRNFL thickness was evaluated longitudinally and was proven to be stable over time. MRI imaging was unremarkable in all cases. Our data support the hypothesis that CACNA1F could be related to early-onset or congenital optic nerve involvement without any signs of a progressive optic neuropathy. Even though additional data from larger cohorts and longer follow-up periods are needed to further support and confirm our findings, there is a clear significance to our findings in the preparation for future CACNA1F gene therapy trials.

Sections du résumé

BACKGROUND
Congenital Stationary Night Blindness (CSNB) constitutes a group of non-progressive retinal disorders characterized by disturbances in scotopic vision and/or by a delay in adaptation to darkness, as well as by low visual acuity, myopia, nystagmus, and strabismus. Color vision and fundus appearance tend to be normal. To date, several CACNA1F gene variants have been linked to a CSNB phenotype but only few reports have focused on the optic nerve in this disease.
MATERIALS AND METHODS
Twelve patients underwent standard ophthalmological and genetic evaluation including spectral domain optical coherence tomography (SD-OCT), full-field electroretinography (ffERG), kinetic perimetry, fundus photography, magnetic resonance imaging (MRI), and next-generation sequencing (NGS). Bilateral thinning of the peripapillary nerve fiber layer (pRNFL) and the ganglion cell complex (GCC) supported involvement of the optic nerves. MRI, when available, was assessed for gross intracranial optic pathway abnormalities.
RESULTS
All patients were shown to carry pathogenic variants in the CACNA1F gene, and all showed signs of optic nerve involvement. All patients showed a certain degree of myopic refractive error. Low average pRNFL thickness was evident in all patients. In three of them, pRNFL thickness was evaluated longitudinally and was proven to be stable over time. MRI imaging was unremarkable in all cases.
CONCLUSION
Our data support the hypothesis that CACNA1F could be related to early-onset or congenital optic nerve involvement without any signs of a progressive optic neuropathy. Even though additional data from larger cohorts and longer follow-up periods are needed to further support and confirm our findings, there is a clear significance to our findings in the preparation for future CACNA1F gene therapy trials.

Identifiants

pubmed: 36469668
doi: 10.1080/13816810.2022.2132514
doi:

Substances chimiques

CACNA1F protein, human 0
Calcium Channels, L-Type 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

152-162

Auteurs

Elisa Marziali (E)

Pediatric Ophthalmology Unit, Meyer Children's Hospital, University of Florence, Florence, Italy.

Filip Van Den Broeck (F)

Department of Ophthalmology and Center for Medical Genetics Ghent, Ghent University Hospital, Ghent, Belgium.

Sara Bargiacchi (S)

Medical Genetics Unit, Meyer Children's Hospital, University of Florence, Florence, Italy.

Pina Fortunato (P)

Pediatric Ophthalmology Unit, Meyer Children's Hospital, University of Florence, Florence, Italy.

Roberto Caputo (R)

Pediatric Ophthalmology Unit, Meyer Children's Hospital, University of Florence, Florence, Italy.

Andrea Sodi (A)

Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.

Julie De Zaeytijd (J)

Department of Ophthalmology and Center for Medical Genetics Ghent, Ghent University Hospital, Ghent, Belgium.

Vittoria Murro (V)

Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.

Dario Pasquale Mucciolo (DP)

Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.

Dario Giorgio (D)

Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.

Ilaria Passerini (I)

Department of Genetic Diagnosis, Careggi Teaching Hospital, Florence, Italy.

Viviana Palazzo (V)

Medical Genetics Unit, Meyer Children's Hospital, University of Florence, Florence, Italy.

Francesca Peluso (F)

Medical Genetics Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Elfride de Baere (E)

Center for Medical Genetics, Ghent University and Ghent University Hospital, Ghent, Belgium.

Christina Zeitz (C)

INSERM, CNRS, Institut de la Vision, Sorbonne Université, Paris, France.

Bart P Leroy (BP)

Department of Ophthalmology and Center for Medical Genetics Ghent, Ghent University Hospital, Ghent, Belgium.
Center for Medical Genetics, Ghent University and Ghent University Hospital, Ghent, Belgium.
Division of Ophthalmology and Center for Cellular and Molecular Therapeutics, Inc, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Jacopo Secci (J)

Pediatric Ophthalmology Unit, Meyer Children's Hospital, University of Florence, Florence, Italy.

Giacomo M Bacci (GM)

Pediatric Ophthalmology Unit, Meyer Children's Hospital, University of Florence, Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH